CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Seshadri Vishwas −$101K Chief Executive Officer sold 2% of stake
- Alvino Mark −$88K Director sold 19% of stake
- Vazzano Joseph Walter −$47K Chief Financial Officer sold 2% of stake
- O'Malley Brendan M. −$35K SVP, Chief Legal Officer sold 2% of stake
- Vasanthavada Madhav −$25K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-26 | Alvino Mark Director | Grant or award | +37,313 | 86,065 | ||
| 2026-01-26 | Alland Leila Director | Grant or award | +37,313 | 191,679 | ||
| 2026-01-22 | Vasanthavada Madhav Chief Commercial Officer | Sale | −12,610 | $5.29 | $67K | 318,619 |
| 2026-01-22 | Vazzano Joseph Walter Chief Financial Officer | Sale | −18,666 | $5.33 | $100K | 568,560 |
| 2026-01-22 | Seshadri Vishwas Chief Executive Officer | Sale | −69,832 | $5.33 | $372K | 1,460,408 |
| 2026-01-22 | O'Malley Brendan M. SVP, Chief Legal Officer | Sale | −13,578 | $5.33 | $72K | 451,134 |
| 2026-01-21 | Alvino Mark Director | Sale | −13,500 | $5.23 | $71K | 48,752 |
| 2026-01-20 | Vasanthavada Madhav Chief Commercial Officer | Grant or award | +76,621 | 331,229 | ||
| 2026-01-20 | Vazzano Joseph Walter Chief Financial Officer | Grant or award | +133,595 | 587,226 | ||
| 2026-01-20 | Seshadri Vishwas Chief Executive Officer | Grant or award | +365,422 | 1,530,240 | ||
| 2026-01-20 | O'Malley Brendan M. SVP, Chief Legal Officer | Grant or award | +113,949 | 464,712 | ||
| 2025-12-29 | Seshadri Vishwas Chief Executive Officer | Sale 10b5-1 | −25,000 | $5.31 | $133K | 1,164,818 |
| 2025-11-13 | Alvino Mark Director | Sale | −15,000 | $4.74 | $71K | 62,252 |
| 2025-10-16 | Seshadri Vishwas Chief Executive Officer | Sale | −249 | $5.49 | $1K | 1,189,818 |
| 2025-09-30 | Seshadri Vishwas Chief Executive Officer | Sale 10b5-1 | −25,000 | $5.24 | $131K | 1,190,067 |
| 2025-09-29 | O'Malley Brendan M. SVP, Chief Legal Officer | Sale | −9,366 | $5.39 | $51K | 350,763 |
| 2025-09-29 | Seshadri Vishwas Chief Executive Officer | Sale 10b5-1 | −19,274 | $5.39 | $104K | 1,215,067 |
| 2025-09-29 | Vazzano Joseph Walter Chief Financial Officer | Sale | −9,035 | $5.39 | $49K | 453,631 |
| 2025-09-22 | O'Malley Brendan M. SVP, Chief Legal Officer | Sale | −688 | $5.43 | $4K | 360,129 |
| 2025-08-15 | Vazzano Joseph Walter Chief Financial Officer | Sale | −15,000 | $7.36 | $110K | 462,666 |
Page 3 of 12 · 223 trades